Evidence map›Paper›PMID 31230195›Full record

ArticleHuman genetics2019

COL4A1 mutations as a potential novel cause of autosomal dominant CAKUT in humans.

Thomas M Kitzler, Ronen Schneider, Stefan Kohl, Caroline M Kolvenbach, Dervla M Connaughton, Rufeng Dai, Nina Mann, Makiko Nakayama, Amar J Majmundar, Chen-Han W Wu and 12 more

Open access · greenAbstract read
In one paragraph

Article in Human genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The genetics and pathogenesis of CAKUT.Nature reviews. Nephrology · 2023
    Review
  11. Review
  12. Association of Elevated Expression Levels ofJournal of personalized medicine · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 4 countries.

Thomas M KitzlerDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Ronen SchneiderDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Stefan KohlDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Caroline M KolvenbachDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Dervla M ConnaughtonDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Rufeng DaiDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Nina MannDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Makiko NakayamaDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Amar J MajmundarDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Chen-Han W WuDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Jameela A KariPediatric Nephrology Center of Excellence and Pediatric Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Sherif M El DesokyPediatric Nephrology Center of Excellence and Pediatric Department, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Prabha SenguttuvanDepartment of Pediatric Nephrology, Dr. Mehta's Multi-Specialty Hospital, Chennai, India.
Radovan BogdanovicDepartment of Pediatric Nephrology, Institute for Mother and Child Health Care, Belgrade, Serbia.
Natasa StajicDepartment of Pediatric Nephrology, Institute for Mother and Child Health Care, Belgrade, Serbia.
Zaheer ValivullahProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Monkol LekDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Shrikant ManeDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Richard P LiftonDepartment of Genetics, Yale University School of Medicine, New Haven, CT, USA.
Velibor TasicUniversity Children's Hospital, Medical Faculty of Skopje, Skopje, Macedonia.
Shirlee ShrilDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA.
Friedhelm HildebrandtDepartment of Medicine, Boston Children's Hospital, Enders 561, Harvard Medical School, 300 Longwood Avenue, Boston, MA, 02115, USA. friedhelm.hildebrandt@childrens.harvard.edu.ORCID http://orcid.org/0000-0002-4167-8411
Boston Children's Hospital · USYale University · USInstitute of Public Health of Serbia · RSKing Abdulaziz University · SABroad Institute · USChildren's Clinical University Hospital · LV

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S. · 2008 to 2022
$16.8M
Joint Center for Mendelian GenomicsUM1HG008900 · NHGRI · BROAD INSTITUTE, INC. · PI O'DONNELL-LURIA, ANNE, REHM, HEIDI L · 2016 to 2020
$16.5M
TRAINING GRANT IN GENETICST32GM007748 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Anne O'Donnell-Luria, Louise Wilkins-Haug · 1985 to 2026
$12.0M
Yale Center for Mendelian DisordersU54HG006504 · NHGRI · YALE UNIVERSITY · PI GERSTEIN, MARK BENDER, GUNEL, MURAT · 2012 to 2015
$11.0M
RESEARCH TRAINING IN PEDIATRIC NEPHROLOGYT32DK007726 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI BRISCOE, DAVID M. · 1994 to 2023
$5.9M
Identification and function of new genes causing childhood nephrotic syndromeR01DK076683 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HILDEBRANDT, FRIEDHELM · 2007 to 2021
$5.3M
New genes and pathomechanisms of congenital abnormalities of the kidney (CAKUT)R01DK088767 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI HILDEBRANDT, FRIEDHELM · 2010 to 2019
$3.4M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysiS10OD018521 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2015 to 2015
$890k
Harvard Stem Cell Institute Kidney Inter-lab Fellowship Award at Harvard Medical School F-KP-0003-17-00Health Research Board, Ireland HPF-206-674KRESCENT - Kidney Foundation of Canada, the Canadian Society of Nephrology, and the Canadian Institutes of Health Research n/aNCATS NIH HHS UL1 TR001863NHGRI NIH HHS U54 HG006504NHGRI NIH HHS UM1 HG008900NIDDK NIH HHS P30 DK079310NIDDK NIH HHS R01 DK076683NIDDK NIH HHS R01 DK088767NIDDK NIH HHS T32 DK007726NIGMS NIH HHS T32 GM007748NIH HHS DK076683NIH HHS S10 OD018521Research Training in Pediatric Nephrology grant T32-DK007726Research Training in Pediatric Nephrology grant T32-GM007748
6 · The paper itself

Abstract

Congenital anomalies of the kidney and urinary tract (CAKUT) are the most common cause of chronic kidney disease (~ 45%) that manifests before 30 years of age. The genetic locus containing COL4A1 (13q33-34) has been implicated in vesicoureteral reflux (VUR), but mutations in COL4A1 have not been reported in CAKUT. We hypothesized that COL4A1 mutations cause CAKUT in humans. We performed whole exome sequencing (WES) in 550 families with CAKUT. As negative control cohorts we used WES sequencing data from patients with nephronophthisis (NPHP) with no genetic cause identified (n = 257) and with nephrotic syndrome (NS) due to monogenic causes (n = 100). We identified a not previously reported heterozygous missense variant in COL4A1 in three siblings with isolated VUR. When examining 549 families with CAKUT, we identified nine additional different heterozygous missense mutations in COL4A1 in 11 individuals from 11 unrelated families with CAKUT, while no COL4A1 mutations were identified in a control cohort with NPHP and only one in the cohort with NS. Most individuals (12/14) had isolated CAKUT with no extrarenal features. The predominant phenotype was VUR (9/14). There were no clinical features of the COL4A1-related disorders (e.g., HANAC syndrome, porencephaly, tortuosity of retinal arteries). Whereas COL4A1-related disorders are typically caused by glycine substitutions in the collagenous domain (84.4% of variants), only one variant in our cohort is a glycine substitution within the collagenous domain (1/10). We identified heterozygous COL4A1 mutations as a potential novel autosomal dominant cause of CAKUT that is allelic to the established COL4A1-related disorders and predominantly caused by non-glycine substitutions.

Indexed as

MutationPhenotypeAllelesAmino Acid SubstitutionCollagen Type IVComputational BiologyCongenital AbnormalitiesDatabases, GeneticDNA Mutational AnalysisEvolution, MolecularExome SequencingFemaleGenetic Association StudiesGenetic LociGenomicsHeterozygoteCOL4A1 protein, humanCollagen Type IV

Identifiers

PMID31230195
PMCPMC6745245
OpenAlexW2952067594

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.